Increased prevalence of silent celiac disease among Greek epileptic children

Antigoni Mavroudi1, Mavroudi Antigoni, Ioannis Xinias

  • 13rd Pediatric Clinic, Aristotle University of Thessaloniki Medical School, Hippocration Hospital, Thessaloniki, Greece.

Pediatric Neurology
|March 14, 2007
PubMed

Insights

Silent celiac disease is more common in children with epilepsy. Testing for tissue transglutaminase IgA antibodies is a good screening method for celiac disease in these patients.

Area of Science:

  • Pediatric Neurology
  • Gastroenterology
  • Immunology

Background:

  • Celiac disease is an immune-mediated enteropathy linked to gluten intake in susceptible individuals.
  • Associations between epilepsy, celiac disease, and intracranial calcifications have been reported.
  • The prevalence of silent celiac disease in pediatric epilepsy requires further investigation.

Purpose of the Study:

  • To investigate the prevalence of celiac disease in children with idiopathic epilepsy.
  • To evaluate the diagnostic utility of specific antibody markers for celiac disease in this population.
  • To determine the association between celiac disease and intracranial calcifications in epileptic children.

Main Methods:

  • Screening 255 children with idiopathic epilepsy for various celiac disease antibodies (IgA, IgG antigliadin, IgA antitissue transglutaminase, IgA antiendomysial, antireticulin).
  • Performing small intestinal biopsies in patients with positive IgA antigliadin antibodies.
  • Comparing findings with 280 healthy control children.

Main Results:

  • Five epileptic children showed intestinal histopathologic changes and/or positive celiac disease antibodies, not observed in controls (P = 0.0241).
  • No intracranial calcifications were found in epileptic children diagnosed with celiac disease.
  • The study identified an increased prevalence of silent celiac disease in children with idiopathic epilepsy.

Conclusions:

  • Silent celiac disease is more prevalent in children with idiopathic epilepsy, irrespective of epilepsy type.
  • Serum IgA antitissue transglutaminase antibodies show promise as a reliable screening marker for celiac disease.
  • Occipital corticosubcortical calcifications appear to be less common in pediatric epilepsy patients with celiac disease.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...